Different effects of thromboxane synthetase inhibition on PGI2 and PGE2 synthesis in human vascular tissue bathed in clotting blood.
Asai
F
F
Pharmakologisches Institut, Universität Köln, FRG.
Schrör
K
K
D001777:Blood Coagulation; D015232:Dinoprostone; D011464:Epoprostenol / Q000096:biosynthesis*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology*; D066298:In Vitro Techniques; D007700:Kinetics; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000378:metabolism*; D011458:Prostaglandins E / Q000096:biosynthesis*; D011725:Pyridines / Q000494:pharmacology*; D013876:Thiophenes / Q000494:pharmacology*; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*; D014469:Umbilical Arteries / Q000187:drug effects / Q000378:metabolism
D007093:Imidazoles; D011458:Prostaglandins E; D011725:Pyridines; D013876:Thiophenes; C029166:dazoxiben; C046339:LG 82-4-00; C037787:pirmagrel; D011464:Epoprostenol; D013930:Thromboxane-A Synthase; D015232:Dinoprostone